Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements - Summary of Impact of Revision on Balance Sheet (Details)

v3.21.4
Restatement of Previously Issued Financial Statements - Summary of Impact of Revision on Balance Sheet (Details) - USD ($)
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2020
Error Corrections And Prior Period Adjustments Restatement [Line Items]        
Common stock subject to possible redemption $ 276,000,000 $ 276,000,000 $ 276,000,000  
Common Stock 690 690 690 $ 690
Additional paid-in capital     0 24,310
Accumulated deficit (9,129,727) (8,691,845) (8,572,256) (526)
Total stockholders' equity (deficit) $ (9,129,037) $ (8,691,155) $ (8,571,566) $ 24,474
Number of shares subject to redemption 27,600,000 27,600,000 27,600,000 0
As Previously Reported        
Error Corrections And Prior Period Adjustments Restatement [Line Items]        
Common stock subject to possible redemption   $ 262,308,840 $ 262,428,430  
Common Stock   827 826  
Additional paid-in capital   5,169,247 5,049,658  
Accumulated deficit   (170,069) (50,480)  
Total stockholders' equity (deficit)   $ 5,000,005 $ 5,000,004  
Number of shares subject to redemption   26,230,884 26,242,843  
Adjustment        
Error Corrections And Prior Period Adjustments Restatement [Line Items]        
Common stock subject to possible redemption   $ 13,691,160 $ 13,571,570  
Common Stock   (137) (136)  
Additional paid-in capital   (5,169,247) (5,049,658)  
Accumulated deficit   (8,521,776) (8,521,776)  
Total stockholders' equity (deficit)   $ (13,691,160) $ (13,571,570)  
Number of shares subject to redemption   1,369,116 1,357,157